AMI Asset Management’s Vera Therapeutics VERA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$1.03M Buy
32,028
+1,446
+5% +$50.6K 0.06% 50
2026
Q2
$1.31M Buy
30,582
+8,630
+39% +$322K 0.08% 43
2026
Q1
$883K Sell
21,952
-6,571
-23% -$283K 0.06% 60
2025
Q4
$1.44M Buy
+28,523
New +$1.01M 0.08% 45

Other funds holding VERA

AMI Asset Management's VERA Position: Q3 2026 in Review

AMI Asset Management increased its Vera Therapeutics (VERA) stake by 4.7% in Q3 2026, buying an estimated $50.6K and bringing the position to 32,028 shares worth $1.03M. The position accounts for 0.06% of the portfolio, ranked #50.

AMI Asset Management first reported a position in VERA in Q4 2025 and has held it in 4 quarters since. The position peaked at $1.44M in Q4 2025. 24 funds tracked by Wall St. Rank hold VERA as of Q3 2026.

  • AMI Asset Management held 32,028 shares of Vera Therapeutics worth $1.03M as of Q3 2026.
  • AMI Asset Management bought 1,446 Vera Therapeutics shares in Q3 2026, an estimated $50.6K.
  • Vera Therapeutics made up 0.06% of AMI Asset Management's portfolio in Q3 2026, its #50 holding.
  • AMI Asset Management first reported a position in Vera Therapeutics in Q4 2025 and has held it in 4 quarters since.
  • AMI Asset Management's Vera Therapeutics position peaked at $1.44M in Q4 2025.
  • 24 funds tracked by Wall St. Rank held Vera Therapeutics as of Q3 2026.

Based on AMI Asset Management's 13F filing for Q3 2026, filed 20 Oct 2026.